2301
Oral Immunotherapy (OIT)
Saturday, March 1, 2014: 10:45 AM-12:00 PM
Convention Center, Ground Level, Exhibit Hall A
1.25 CME/ 1.50 CE
Moderator:
J. Andrew Bird , MD FAAAAI
Learning Objectives:
  1. Identify patients with IgE-mediated food allergy who represent a target for OIT
  2. Examine different protocols for different foods
  3. Outline the risk-benefit ratio of OIT
10:45 AM
Current Protocols for Oral Immunotherapy
Kari C. Nadeau, MD PhD FAAAAI
11:05 AM
Oral Immunotherapy: Native or Modified Allergen?
Hugh A. Sampson, MD FAAAAI
11:25 AM
When Should We Stop Oral Immunotherapy? When Should it be Restarted?
Giovanni B. Pajno, MD FAAAAI
11:45 AM
Question & Answer
See more of: Symposia